Pub Date : 2025-02-06eCollection Date: 2025-01-01DOI: 10.2147/IDR.S506658
Wen Zhu, Yi Liang, Jie Xu, Chao Weng
Purpose: Carbapenem-resistant organisms (CROs) have been listed as the primary risk resistance bacteria due to their high detection rates and extensive drug resistance. Research on the effectiveness of CRO intervention programs in secondary hospitals is limited. This study aims to observe the effect of multidisciplinary-based and bundle interventions under PDCA (plan-do-check-act) cycle management on the control of CROs in neurosurgery.
Patients and methods: We conducted a before-after study from January 2021 to December 2023, which was divided into pre-intervention phase and intervention phase. The surveillance analysis and event analysis were used to identify the key links and targeted pathogens of the intervention. PDCA cycle management tool was used to strengthen the bundle management of multidisciplinary collaboration. After one year of PDCA intervention, the process surveillance and outcome surveillance indicators of prevention and control measures from January 2023 to December 2023 were collected and compared with the pre-intervention phase (January 2021-December 2022).
Results: A total of 1809 patients were involved in our study. The 11 prevention and control measures were evaluated. After the implementation of PDCA cycle management, the measures including timely completion of multi-drug resistance prevention and control registration, and issuance of contact precaution orders, were significantly improved (p < 0.05). The total detection rate of CRO strains was 52.25%, which was significantly lower than 66.45% before intervention (RR = 0.786; 95% CI, 0.678-0.912; p < 0.05), and the incidence density of patients infected or colonized with CROs showed significant decrease from 18.75 per 1000 patient-days to 15.09 per 1000 patient-days (IRR = 0.563; 95% CI, 0.449-0.707; p < 0.05).
Conclusion: The multidisciplinary and bundle interventions based on PDCA cycle management tool had a good effect on the prevention and control of CROs in neurosurgery.
{"title":"A Multidisciplinary-Based and Bundle Intervention for Controlling Carbapenem-Resistant Organisms in Neurosurgery.","authors":"Wen Zhu, Yi Liang, Jie Xu, Chao Weng","doi":"10.2147/IDR.S506658","DOIUrl":"10.2147/IDR.S506658","url":null,"abstract":"<p><strong>Purpose: </strong>Carbapenem-resistant organisms (CROs) have been listed as the primary risk resistance bacteria due to their high detection rates and extensive drug resistance. Research on the effectiveness of CRO intervention programs in secondary hospitals is limited. This study aims to observe the effect of multidisciplinary-based and bundle interventions under PDCA (plan-do-check-act) cycle management on the control of CROs in neurosurgery.</p><p><strong>Patients and methods: </strong>We conducted a before-after study from January 2021 to December 2023, which was divided into pre-intervention phase and intervention phase. The surveillance analysis and event analysis were used to identify the key links and targeted pathogens of the intervention. PDCA cycle management tool was used to strengthen the bundle management of multidisciplinary collaboration. After one year of PDCA intervention, the process surveillance and outcome surveillance indicators of prevention and control measures from January 2023 to December 2023 were collected and compared with the pre-intervention phase (January 2021-December 2022).</p><p><strong>Results: </strong>A total of 1809 patients were involved in our study. The 11 prevention and control measures were evaluated. After the implementation of PDCA cycle management, the measures including timely completion of multi-drug resistance prevention and control registration, and issuance of contact precaution orders, were significantly improved (<i>p</i> < 0.05). The total detection rate of CRO strains was 52.25%, which was significantly lower than 66.45% before intervention (RR = 0.786; 95% CI, 0.678-0.912; <i>p</i> < 0.05), and the incidence density of patients infected or colonized with CROs showed significant decrease from 18.75 per 1000 patient-days to 15.09 per 1000 patient-days (IRR = 0.563; 95% CI, 0.449-0.707; <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>The multidisciplinary and bundle interventions based on PDCA cycle management tool had a good effect on the prevention and control of CROs in neurosurgery.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"757-768"},"PeriodicalIF":2.9,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143390793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Pyogenic thoracic spondylitis is a rare but severe infection, particularly when complicated by sepsis and acute kidney injury (AKI). Early diagnosis and precise management are essential for improving outcomes, given the limitations of traditional microbiology detection methods in identifying the causative pathogens.
Case presentation: A 68-year-old immunocompetent male presented with recurrent fever, fatigue, loss of appetite and initial evidence of sepsis and AKI upon admission. With the prompt computed tomography (CT)-guided percutaneous biopsy of the thoracic vertebrae, Escherichia coli was identified as the causative pathogen using metagenomic next-generation sequencing (mNGS). A diagnosis of pyogenic thoracic spondylitis was then made followed by the treatment of antibiotics optimized by therapeutic drug monitoring (TDM) techniques. With a total effective antibiotic treatment period of 7 weeks, the patient recovered without resorting to surgical interventions.
Conclusion: This is a rare case of acute thoracic spondylitis caused by E. coli, successfully treated without surgery. This case highlights the significant challenges in diagnosis and treatment. It underscores the value of mNGS in identifying rare infections and emphasizes the role of TDM in optimizing antibiotic therapy, providing a reference for future cases of rare and critical infections with fever of unknown origin.
{"title":"<i>Escherichia coli</i> in the T11-12 Thoracic Vertebrae: A Case Report.","authors":"Dandan Weng, Hongyuan Zhou, Guancheng Huang, Qingren Cao, Huafeng Wang, Zhujun Cao, Qing Xie","doi":"10.2147/IDR.S506265","DOIUrl":"10.2147/IDR.S506265","url":null,"abstract":"<p><strong>Background: </strong>Pyogenic thoracic spondylitis is a rare but severe infection, particularly when complicated by sepsis and acute kidney injury (AKI). Early diagnosis and precise management are essential for improving outcomes, given the limitations of traditional microbiology detection methods in identifying the causative pathogens.</p><p><strong>Case presentation: </strong>A 68-year-old immunocompetent male presented with recurrent fever, fatigue, loss of appetite and initial evidence of sepsis and AKI upon admission. With the prompt computed tomography (CT)-guided percutaneous biopsy of the thoracic vertebrae, <i>Escherichia coli</i> was identified as the causative pathogen using metagenomic next-generation sequencing (mNGS). A diagnosis of pyogenic thoracic spondylitis was then made followed by the treatment of antibiotics optimized by therapeutic drug monitoring (TDM) techniques. With a total effective antibiotic treatment period of 7 weeks, the patient recovered without resorting to surgical interventions.</p><p><strong>Conclusion: </strong>This is a rare case of acute thoracic spondylitis caused by <i>E. coli</i>, successfully treated without surgery. This case highlights the significant challenges in diagnosis and treatment. It underscores the value of mNGS in identifying rare infections and emphasizes the role of TDM in optimizing antibiotic therapy, providing a reference for future cases of rare and critical infections with fever of unknown origin.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"693-702"},"PeriodicalIF":2.9,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143390792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To analyze the clinical distribution and antimicrobial resistance of Pseudomonas aeruginosa (P. aeruginosa) isolated from blood specimens in 75 hospitals in Hebei Province from 2016 to 2021 to aid in the rational selection of antimicrobial drugs.
Patients and methods: WHONET 5.6 and SPSS 24.0 were used to retrospectively analyze clinical distribution characteristics and variations in drug-resistance.
Results: Between 2016 and 2021, 2208 P. aeruginosa strains were detected in blood specimens from Hebei Province. The median age of the patients with isolated P. aeruginosa was 63 years, with a male-to-female ratio of 2.1:1. Predominantly, patients were in the hematology (20.7%) and critical care medicine (18.4%) departments. During the monitoring period, the resistance rate of P. aeruginosa to various antibacterial drugs, such as aminoglycosides, fluoroquinolones, and carbapenems, decreased to varying degrees, with an average resistance rate of less than 20.0% over six years. Resistance rates were notably higher in pediatric and intensive care medicine, particularly in neonatal patients, where resistance to antimicrobial drugs, such as piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin, exceeded 75%.
Conclusion: The main isolates of P. aeruginosa were from elderly and intensive care patients, with a male predominance. From 2016 to 2021, the resistance rate of P. aeruginosa isolated from blood specimens in Hebei Province to various antibiotics such as aminoglycosides, fluoroquinolones, and carbapenems decreased to varying degrees. The resistance rates are high in pediatric and intensive care medicine, especially among neonatal patients. However, resistance to antibiotics varies with age and department, necessitating tailored antimicrobial administration. The issue of antibacterial drug resistance in newborn patients is concerning, and special attention is needed when during treatment.
{"title":"Multicenter Surveillance of <i>Pseudomonas aeruginosa</i> Isolates From Blood: Clinical Distribution Characteristics and Antibiotic Resistance Trends in Hebei Province, China (2016-2021).","authors":"Cuixin Qiang, Xiaoxuan Liu, Pu Qin, Hainan Wen, Zhirong Li, Jing Yang, Yanan Niu, Weigang Wang, Zirou Ouyang, Min Zhao, Jiayiren Li, Yulian Zhang, Jianhong Zhao","doi":"10.2147/IDR.S489527","DOIUrl":"10.2147/IDR.S489527","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the clinical distribution and antimicrobial resistance of <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) isolated from blood specimens in 75 hospitals in Hebei Province from 2016 to 2021 to aid in the rational selection of antimicrobial drugs.</p><p><strong>Patients and methods: </strong>WHONET 5.6 and SPSS 24.0 were used to retrospectively analyze clinical distribution characteristics and variations in drug-resistance.</p><p><strong>Results: </strong>Between 2016 and 2021, 2208 <i>P. aeruginosa</i> strains were detected in blood specimens from Hebei Province. The median age of the patients with isolated <i>P. aeruginosa</i> was 63 years, with a male-to-female ratio of 2.1:1. Predominantly, patients were in the hematology (20.7%) and critical care medicine (18.4%) departments. During the monitoring period, the resistance rate of <i>P. aeruginosa</i> to various antibacterial drugs, such as aminoglycosides, fluoroquinolones, and carbapenems, decreased to varying degrees, with an average resistance rate of less than 20.0% over six years. Resistance rates were notably higher in pediatric and intensive care medicine, particularly in neonatal patients, where resistance to antimicrobial drugs, such as piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin, exceeded 75%.</p><p><strong>Conclusion: </strong>The main isolates of <i>P. aeruginosa</i> were from elderly and intensive care patients, with a male predominance. From 2016 to 2021, the resistance rate of <i>P. aeruginosa</i> isolated from blood specimens in Hebei Province to various antibiotics such as aminoglycosides, fluoroquinolones, and carbapenems decreased to varying degrees. The resistance rates are high in pediatric and intensive care medicine, especially among neonatal patients. However, resistance to antibiotics varies with age and department, necessitating tailored antimicrobial administration. The issue of antibacterial drug resistance in newborn patients is concerning, and special attention is needed when during treatment.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"703-713"},"PeriodicalIF":2.9,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143390846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-04eCollection Date: 2025-01-01DOI: 10.2147/IDR.S501622
Qianqian Gu, Lingren Zhou, Xiaofei Shen, Le Xu, Guixian Wu, Weijia Pan, Wenxia Lin, Dongqing Lv, Ling Lin, Shuangquan Yan
Nocardiosis caused by Nocardia otitidiscaviarum is exceptionally rare and characterized by a high mortality rate. It typically affects immunocompromised patients, resulting in severe pulmonary or disseminated infections, and is notorious for abscess formation. Empyema resulting from nocardiosis is even less common. Early clinical signs and imaging findings lack specificity, culture growth is sluggish, and the absence of an effective serological detection method can delay treatment. We report an 81-year-old patient with chronic obstructive pulmonary disease treated by long-term inhalation of high-dose salmeterol fluticasone. The initial empirical anti-infection treatment proved ineffective, resulting in rapid disease progression before the confirmation of nocardiosis with empyema through cultures of pleural fluid and sputum. Despite active treatment measures, the patient succumbed to severe pulmonary infection, sepsis, and multiple organ failure. A review of the literature, together with clinical experience, indicates that conventional empirical treatment for Nocardia otitidiscaviarum infection may not always be effective due to the escalating rate of drug resistance. Therefore, the primary step in the management of the infection is timely diagnosis using different methods. Furthermore, the identification of the responsible strain followed by conducting drug sensitivity tests is paramount for the successful treatment of this disease.
{"title":"Fatal Empyema Thoracis Caused by <i>Nocardia otitidiscaviarum</i>.","authors":"Qianqian Gu, Lingren Zhou, Xiaofei Shen, Le Xu, Guixian Wu, Weijia Pan, Wenxia Lin, Dongqing Lv, Ling Lin, Shuangquan Yan","doi":"10.2147/IDR.S501622","DOIUrl":"10.2147/IDR.S501622","url":null,"abstract":"<p><p>Nocardiosis caused by <i>Nocardia otitidiscaviarum</i> is exceptionally rare and characterized by a high mortality rate. It typically affects immunocompromised patients, resulting in severe pulmonary or disseminated infections, and is notorious for abscess formation. Empyema resulting from nocardiosis is even less common. Early clinical signs and imaging findings lack specificity, culture growth is sluggish, and the absence of an effective serological detection method can delay treatment. We report an 81-year-old patient with chronic obstructive pulmonary disease treated by long-term inhalation of high-dose salmeterol fluticasone. The initial empirical anti-infection treatment proved ineffective, resulting in rapid disease progression before the confirmation of nocardiosis with empyema through cultures of pleural fluid and sputum. Despite active treatment measures, the patient succumbed to severe pulmonary infection, sepsis, and multiple organ failure. A review of the literature, together with clinical experience, indicates that conventional empirical treatment for <i>Nocardia otitidiscaviarum</i> infection may not always be effective due to the escalating rate of drug resistance. Therefore, the primary step in the management of the infection is timely diagnosis using different methods. Furthermore, the identification of the responsible strain followed by conducting drug sensitivity tests is paramount for the successful treatment of this disease.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"669-678"},"PeriodicalIF":2.9,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-04eCollection Date: 2025-01-01DOI: 10.2147/IDR.S505133
Lei Liu, Bin Liu, Liang Li, Yu Li, Xiangdong Zhou, Qi Li
Objective: This study assesses the efficacy of antimicrobial stewardship (AMS) and infection prevention and control programmes (IPCP) in guiding the use of antibiotics and the control of A. baumannii (AB) resistance at multiple medical centres.
Methods: We evaluated the effectiveness of the policy on antibiotic consumption and AB resistance by determining the relationship between the defined daily doses (DDD) for antibiotics - or alcohol-based hand gel (ABHG) consumption - and the incidence of carbapenem-resistant AB (CR-AB), multidrug-resistant AB (MDR-AB) and extensively drug-resistant AB (XDR-AB) at two medical centers from 2016-2023.
Results: In total, 4057 AB isolates were collected; 64.95% of the AB isolates were CR, 59.48% were MDR and 1.41% were XDR. The major categories of the AB clinical strains collected were extracted primarily from patients' respiratory tract specimens, the ICU wards and patients over 65 years old, accounting for 76.98%, 67.98% and 63.72%, respectively. The incidence of CR-AB, MDR-AB and XDR-AB based on AMS and IPCP measures ranged from 70.04% to 58.42% (P<0.0001), 64.26% to 52.16% (P<0.0001) and 2.27% to 0.60% (P=0.0167), respectively. The DDD of total antibiotics administered per 1000 patient days (PD) decreased significantly from 51.25±4.22 to 40.92±2.48 (P<0.0001), and ABHG consumption per 1000 PD increased significantly from 5.25±0.98 to 13.51±5.12 (P<0.0001). We found a statistically significant positive correlation between the DDD of antibiotic consumption and the incidence of CR-AB, MDR-AB and XDR-AB (r=0.9755 and P<0.0001, r=0.9571 and P=0.0002, r=0.9230 and p=0.0011, respectively). In addition, a statistically negative correlation was found between ABHG consumption and the incidence of CR-AB, MDR-AB, and XDR-AB (r=-0.9473 and P=0.0004, r=-0.9123 and P=0.0016, r=-0.9138 and P=0.0015, respectively).
Conclusion: Comprehensive AMS and IPCP intervention measures can successfully achieve a sustained amelioration in the resistance and transmission of CR-AB, MDR-AB and XDR-AB, which are regarding potential applicability to other hospitals.
{"title":"Impact of Antimicrobial Stewardship and Infection Prevention and Control Programmes on Antibiotic Usage and <i>A. baumannii</i> resistance: A 2016-2023 Multicentre Prospective Study.","authors":"Lei Liu, Bin Liu, Liang Li, Yu Li, Xiangdong Zhou, Qi Li","doi":"10.2147/IDR.S505133","DOIUrl":"10.2147/IDR.S505133","url":null,"abstract":"<p><strong>Objective: </strong>This study assesses the efficacy of antimicrobial stewardship (AMS) and infection prevention and control programmes (IPCP) in guiding the use of antibiotics and the control of <i>A. baumannii</i> (AB) resistance at multiple medical centres.</p><p><strong>Methods: </strong>We evaluated the effectiveness of the policy on antibiotic consumption and AB resistance by determining the relationship between the defined daily doses (DDD) for antibiotics - or alcohol-based hand gel (ABHG) consumption - and the incidence of carbapenem-resistant AB (CR-AB), multidrug-resistant AB (MDR-AB) and extensively drug-resistant AB (XDR-AB) at two medical centers from 2016-2023.</p><p><strong>Results: </strong>In total, 4057 AB isolates were collected; 64.95% of the AB isolates were CR, 59.48% were MDR and 1.41% were XDR. The major categories of the AB clinical strains collected were extracted primarily from patients' respiratory tract specimens, the ICU wards and patients over 65 years old, accounting for 76.98%, 67.98% and 63.72%, respectively. The incidence of CR-AB, MDR-AB and XDR-AB based on AMS and IPCP measures ranged from 70.04% to 58.42% (P<0.0001), 64.26% to 52.16% (P<0.0001) and 2.27% to 0.60% (P=0.0167), respectively. The DDD of total antibiotics administered per 1000 patient days (PD) decreased significantly from 51.25±4.22 to 40.92±2.48 (P<0.0001), and ABHG consumption per 1000 PD increased significantly from 5.25±0.98 to 13.51±5.12 (P<0.0001). We found a statistically significant positive correlation between the DDD of antibiotic consumption and the incidence of CR-AB, MDR-AB and XDR-AB (r=0.9755 and P<0.0001, r=0.9571 and P=0.0002, r=0.9230 and p=0.0011, respectively). In addition, a statistically negative correlation was found between ABHG consumption and the incidence of CR-AB, MDR-AB, and XDR-AB (r=-0.9473 and P=0.0004, r=-0.9123 and P=0.0016, r=-0.9138 and P=0.0015, respectively).</p><p><strong>Conclusion: </strong>Comprehensive AMS and IPCP intervention measures can successfully achieve a sustained amelioration in the resistance and transmission of CR-AB, MDR-AB and XDR-AB, which are regarding potential applicability to other hospitals.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"679-692"},"PeriodicalIF":2.9,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Procalcitonin (PCT) to albumin (ALB) ratio (PAR) in initial three days is a rapidly available indicator to assess the prognosis of patients with sepsis. This study aims to explore the correlation between changes in PAR during the initial 72 hours and the incidence of secondary infections.
Methods: A total of 147 patients with sepsis were included in this study. Patients divided into secondary infection and without secondary infection group, according to whether they had secondary infection. PAR was calculated as serum PCT (ng/mL)/ALB (mg/mL). All statistical analyses were performed using the statistical package SPSS 20.0.
Results: Compared with the without secondary infection group, the median APACHE II (22[17-30] vs 16[11-25]; p=0.009) were significantly higher in the secondary infection group. And the median ΔPCT/ALB adm-72h (0.10[0.02-0.48] vs 0.17[0.03-0.65]; p=0.011) were significantly lower in the secondary infection group. On multiple logistic regression, lower ΔPCT/ALB adm-72h was independently associated with the secondary infection. Decreasing quartile of ΔPCT/ALB adm-72h was statistically significantly associated with secondary infection, particularly among survivors.
Conclusion: The decline in the PCT/ALB ratio over the initial 72 hours of the acute phase of sepsis serves as an association for the onset of secondary infections during a septic patient's hospitalization.
{"title":"PCT/ALB Ratio in Initial Three days for the Prediction of Secondary Infection in Septic Patients.","authors":"Chunmei Zhang, Guoge Huang, Haizhong Li, Tiancao Zhang, Mengling Jian, Chunyang Huang, Yingqin Zhang, Zheng Wang, Xun Hou, Yuanyuan Xia, Wenqiang Jiang","doi":"10.2147/IDR.S502537","DOIUrl":"10.2147/IDR.S502537","url":null,"abstract":"<p><strong>Background: </strong>Procalcitonin (PCT) to albumin (ALB) ratio (PAR) in initial three days is a rapidly available indicator to assess the prognosis of patients with sepsis. This study aims to explore the correlation between changes in PAR during the initial 72 hours and the incidence of secondary infections.</p><p><strong>Methods: </strong>A total of 147 patients with sepsis were included in this study. Patients divided into secondary infection and without secondary infection group, according to whether they had secondary infection. PAR was calculated as serum PCT (ng/mL)/ALB (mg/mL). All statistical analyses were performed using the statistical package SPSS 20.0.</p><p><strong>Results: </strong>Compared with the without secondary infection group, the median APACHE II (22[17-30] vs 16[11-25]; p=0.009) were significantly higher in the secondary infection group. And the median ΔPCT/ALB adm-72h (0.10[0.02-0.48] vs 0.17[0.03-0.65]; p=0.011) were significantly lower in the secondary infection group. On multiple logistic regression, lower ΔPCT/ALB adm-72h was independently associated with the secondary infection. Decreasing quartile of ΔPCT/ALB adm-72h was statistically significantly associated with secondary infection, particularly among survivors.</p><p><strong>Conclusion: </strong>The decline in the PCT/ALB ratio over the initial 72 hours of the acute phase of sepsis serves as an association for the onset of secondary infections during a septic patient's hospitalization.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"625-633"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Periprosthetic joint infection (PJI) is a serious complication following total joint arthroplasty (TJA), which requires prompt and accurate diagnosis for effective management. Many biomarkers have been used for PJI diagnosis; however, the identification of the most effective inflammatory biomarker combination for optimal diagnostic accuracy may be poorly reported.
Methods: In this prospective, multi-center study, a total of 269 individuals undergoing knee or hip revision arthroplasty were recruited and subsequently categorized based on 2018 ICM PJI criteria into two groups: 93 with periprosthetic joint infection (PJI) and 176 with aseptic failure (AF). Various preoperative biomarkers were analyzed and compared, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), CRP-to-albumin ratio (CAR), CRP-Albumin-lymphocyte ratio (CALLR), platelet-to-lymphocyte ratio (PLR), platelet-to-albumin ratio (PAR), and neutrophil-to-albumin ratio (NAR). The diagnostic performance of these biomarkers was evaluated using ROC curve analysis and the area under the curve (AUC). Additionally, the Youden index was used to determine optimal threshold values, and positive predictive value (PPV) and negative predictive value (NPV) were calculated to evaluate diagnostic precision.
Results: In the PJI group, levels of PAR, CAR, and CALLY were notably higher compared to the AF group, reaching statistical significance (P < 0.05). PAR and CAR were confirmed to have high diagnostic values, with AUC values of 0.779 and 0.718, respectively. CALLY exhibited moderate diagnostic effectiveness, with an AUC of 0.647. When PAR was combined with CRP and ESR, sensitivity and specificity notably improved to 93.8% and 92.5%, respectively. However, subgroup analysis revealed no significant differences in combined inflammatory biomarker levels between the two groups.
Conclusion: PAR and CAR prove to be effective combined inflammatory biomarkers for PJI diagnosis, whereas other markers exhibited limited diagnostic utility for PJI.
{"title":"Blood Cell Ratio Combinations for Diagnosing Periprosthetic Joint Infections: A Preliminary Study.","authors":"Yali Yu, Yanan Wen, Jiaxuan Xia, Guixiang Dong, Yanli Niu","doi":"10.2147/IDR.S489201","DOIUrl":"10.2147/IDR.S489201","url":null,"abstract":"<p><strong>Background: </strong>Periprosthetic joint infection (PJI) is a serious complication following total joint arthroplasty (TJA), which requires prompt and accurate diagnosis for effective management. Many biomarkers have been used for PJI diagnosis; however, the identification of the most effective inflammatory biomarker combination for optimal diagnostic accuracy may be poorly reported.</p><p><strong>Methods: </strong>In this prospective, multi-center study, a total of 269 individuals undergoing knee or hip revision arthroplasty were recruited and subsequently categorized based on 2018 ICM PJI criteria into two groups: 93 with periprosthetic joint infection (PJI) and 176 with aseptic failure (AF). Various preoperative biomarkers were analyzed and compared, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), CRP-to-albumin ratio (CAR), CRP-Albumin-lymphocyte ratio (CALLR), platelet-to-lymphocyte ratio (PLR), platelet-to-albumin ratio (PAR), and neutrophil-to-albumin ratio (NAR). The diagnostic performance of these biomarkers was evaluated using ROC curve analysis and the area under the curve (AUC). Additionally, the Youden index was used to determine optimal threshold values, and positive predictive value (PPV) and negative predictive value (NPV) were calculated to evaluate diagnostic precision.</p><p><strong>Results: </strong>In the PJI group, levels of PAR, CAR, and CALLY were notably higher compared to the AF group, reaching statistical significance (P < 0.05). PAR and CAR were confirmed to have high diagnostic values, with AUC values of 0.779 and 0.718, respectively. CALLY exhibited moderate diagnostic effectiveness, with an AUC of 0.647. When PAR was combined with CRP and ESR, sensitivity and specificity notably improved to 93.8% and 92.5%, respectively. However, subgroup analysis revealed no significant differences in combined inflammatory biomarker levels between the two groups.</p><p><strong>Conclusion: </strong>PAR and CAR prove to be effective combined inflammatory biomarkers for PJI diagnosis, whereas other markers exhibited limited diagnostic utility for PJI.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"635-645"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01eCollection Date: 2025-01-01DOI: 10.2147/IDR.S501632
Qiuyan Wang, Tao Yan, Chengcheng Ma, Xuan Teng, Chengyin Shen, Na Wang, Kexue Yu, Wenwen Chu, Qiang Zhou, Zhou Liu
Purpose: This study aims to investigate the relationship between glycemic control and epidemiological characteristics of patients infected with carbapenem-resistant Klebsiella pneumoniae (CRKP), to identify mortality risk factors associated with CRKP infection, and to evaluate the impact of glucose on the resistance of CRKP to polymyxin and serum killing.
Patients and methods: Clinical cases of 218 patients infected with CRKP were collected from a large tertiary public hospital in Anhui Province. We analyzed whether the glycemic control impacts the clinical and laboratory manifestations of infected patients. Logistic regression identified mortality risk factors. Antibiotic sensitivity, capsular serotypes, and virulence genes were tested of the strains. Three clinically isolated CRKP strains were used to investigate the effect of glucose on bacterial capsule synthesis and the impact on bacterial resistance to polymyxin and serum killing.
Results: Patients with poor glycemic control experienced more severe infections and had a higher likelihood of chronic kidney disease (CKD) and acute renal insufficiency compared to those with good glycemic control. They also exhibited an increased mortality rate. Logistic regression analysis identified age, glycosylated hemoglobin (HbA1c) ≥7%, CKD, tumor, mechanical ventilation, and sepsis as independent risk factors for death associated with CRKP infection. A 0.5% (0.5 g/100mL) glucose environment can stimulate CRKP capsule synthesis, which is inhibitable by cyclic adenosine monophosphate (cAMP). Moreover, a high-glucose environment can enhance CRKP's resistance to polymyxin and serum killing.
Conclusion: A persistent hyperglycemic environment resulting from poor glycemic control may stimulate the synthesis of CRKP capsules, which could enhance the resistance of CRKP to polymyxin and serum killing, thereby further increasing the risk of patient mortality.
{"title":"Poor Glycemic Control in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infections: Impact on Epidemiological Features, Mortality Risks, and Polymyxin Resistance.","authors":"Qiuyan Wang, Tao Yan, Chengcheng Ma, Xuan Teng, Chengyin Shen, Na Wang, Kexue Yu, Wenwen Chu, Qiang Zhou, Zhou Liu","doi":"10.2147/IDR.S501632","DOIUrl":"10.2147/IDR.S501632","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to investigate the relationship between glycemic control and epidemiological characteristics of patients infected with carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP), to identify mortality risk factors associated with CRKP infection, and to evaluate the impact of glucose on the resistance of CRKP to polymyxin and serum killing.</p><p><strong>Patients and methods: </strong>Clinical cases of 218 patients infected with CRKP were collected from a large tertiary public hospital in Anhui Province. We analyzed whether the glycemic control impacts the clinical and laboratory manifestations of infected patients. Logistic regression identified mortality risk factors. Antibiotic sensitivity, capsular serotypes, and virulence genes were tested of the strains. Three clinically isolated CRKP strains were used to investigate the effect of glucose on bacterial capsule synthesis and the impact on bacterial resistance to polymyxin and serum killing.</p><p><strong>Results: </strong>Patients with poor glycemic control experienced more severe infections and had a higher likelihood of chronic kidney disease (CKD) and acute renal insufficiency compared to those with good glycemic control. They also exhibited an increased mortality rate. Logistic regression analysis identified age, glycosylated hemoglobin (HbA<sub>1c</sub>) ≥7%, CKD, tumor, mechanical ventilation, and sepsis as independent risk factors for death associated with CRKP infection. A 0.5% (0.5 g/100mL) glucose environment can stimulate CRKP capsule synthesis, which is inhibitable by cyclic adenosine monophosphate (cAMP). Moreover, a high-glucose environment can enhance CRKP's resistance to polymyxin and serum killing.</p><p><strong>Conclusion: </strong>A persistent hyperglycemic environment resulting from poor glycemic control may stimulate the synthesis of CRKP capsules, which could enhance the resistance of CRKP to polymyxin and serum killing, thereby further increasing the risk of patient mortality.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"647-660"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pantoea is a prevalent environmental Gram-negative bacterium comprising over 20 distinct species. It is a facultative anaerobe capable of forming smooth, translucent colonies on culture plates. Pantoea is typically considered a potential pathogen that may cause infections in plants and animals. With the advancement in mass spectrometry and gene sequencing technologies, human infections caused by Pantoea have increasingly been recognized, raising concerns regarding its pathogenicity and nosocomial transmission that clinicians must address. While there are numerous reports documenting P. agglomerans as a cause of human infections in clinical settings, instances of P. dispersa leading to human pathogenesis are comparatively rare, and the clinical manifestations associated with P. dispersa infections remain largely underexplored. We report a case of a 9-month-old female patient from China whose blood cultures indicated positive Gram-negative bacilli. Through MALDI Biotyper and next-generation sequencing techniques, the pathogen was identified as P. dispersa. Clinically, meropenem was administered for treatment, and the patient's condition improved. We hope this article will help clinicians pay more attention to and better understand infant-related bloodstream infections caused by P. dispersa.
{"title":"The First Infant Bloodstream Infection Caused by <i>Pantoea dispersa</i> in China: A Case Report and Literature Review.","authors":"Wenwen Yu, Zhaohui Sun, Mengyuan Wang, Zheng Li, Chunyan Zhang, Yanmeng Sun, Shifu Wang","doi":"10.2147/IDR.S496299","DOIUrl":"10.2147/IDR.S496299","url":null,"abstract":"<p><p><i>Pantoea</i> is a prevalent environmental Gram-negative bacterium comprising over 20 distinct species. It is a facultative anaerobe capable of forming smooth, translucent colonies on culture plates. <i>Pantoea</i> is typically considered a potential pathogen that may cause infections in plants and animals. With the advancement in mass spectrometry and gene sequencing technologies, human infections caused by <i>Pantoea</i> have increasingly been recognized, raising concerns regarding its pathogenicity and nosocomial transmission that clinicians must address. While there are numerous reports documenting <i>P. agglomerans</i> as a cause of human infections in clinical settings, instances of <i>P. dispersa</i> leading to human pathogenesis are comparatively rare, and the clinical manifestations associated with <i>P. dispersa</i> infections remain largely underexplored. We report a case of a 9-month-old female patient from China whose blood cultures indicated positive Gram-negative bacilli. Through MALDI Biotyper and next-generation sequencing techniques, the pathogen was identified as <i>P. dispersa</i>. Clinically, meropenem was administered for treatment, and the patient's condition improved. We hope this article will help clinicians pay more attention to and better understand infant-related bloodstream infections caused by <i>P. dispersa</i>.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"661-667"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11797003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-31eCollection Date: 2025-01-01DOI: 10.2147/IDR.S499804
Hai Ha Long Le, Luong Cong Thuc, Thang Ba Ta, Tien Viet Tran, Dinh Viet Hung, Hoang Trung Kien, Minh Nhat Le, Vu Huy Luong, Vinh Thi Ha Nguyen, Hoa Quynh Pham, Hung Van Le, Nguyen Hoang Viet, Le Huy Hoang, Tram Thuy Nguyen, Mixay Latsavong, Tuan Dinh Le, Dao Trong Tuan, Nguyen Van An
Purpose: In a Vietnamese teaching hospital, this study examined the prevalence and patterns of antimicrobial resistance (AMR) of common bacteria isolated from hospitalized patients with urinary tract infections (UTIs) between 2014 and 2021.
Methods: From 4060 urine samples collected, common pathogens were isolated using quantitative culture on brilliance UTI Clarity agar and blood agar. Bacterial identification, antimicrobial susceptibility testing, and multidrug resistance (MDR) classification followed standardized techniques. Bacteria with a frequency of less than 2% were excluded. Statistical analysis was performed using R software, with the chi-square test applied and significance set at p < 0.05.
Results: Of 4060 urine samples collected, 892 (22.0%) had positive results for common infections. Gram-negative bacteria predominated (591/892; 66.3%), with Escherichia coli being the most prevalent (336/892; 37.7%). Enterococcus spp. (152/892; 17.0%) was the leading Gram-positive pathogen. Some antibiotics had significant resistance rates, especially in Gram-negative bacteria, with ampicillin having the greatest resistance rate (92.8%). Carbapenems and nitrofurantoin remained generally effective. Among Gram-positive bacteria, high resistance was seen for macrolides ranging from 85.5% (azithromycin) to 89.8% (erythromycin), and for tetracyclines, ranging from 0% (teicoplanin) to 85.2% (tetracycline). There was no resistance to tigecycline and teicoplanin, indicating their potential efficacy against multidrug resistance (MDR) bacteria causing UTIs. MDR rates were higher in Gram-negative bacteria (64.8% versus 43.5%), with Klebsiella pneumoniae having the highest rate (78.7%).
Conclusion: This study underscores the urgent need for ongoing surveillance of AMR patterns in Vietnam and emphasizes the significance of efficient infection prevention methods, prudent use of antibiotics, and targeted interventions to combat antimicrobial resistance.
{"title":"Prevailing Antibiotic Resistance Patterns in Hospitalized Patients with Urinary Tract Infections in a Vietnamese Teaching Hospital (2014 - 2021).","authors":"Hai Ha Long Le, Luong Cong Thuc, Thang Ba Ta, Tien Viet Tran, Dinh Viet Hung, Hoang Trung Kien, Minh Nhat Le, Vu Huy Luong, Vinh Thi Ha Nguyen, Hoa Quynh Pham, Hung Van Le, Nguyen Hoang Viet, Le Huy Hoang, Tram Thuy Nguyen, Mixay Latsavong, Tuan Dinh Le, Dao Trong Tuan, Nguyen Van An","doi":"10.2147/IDR.S499804","DOIUrl":"10.2147/IDR.S499804","url":null,"abstract":"<p><strong>Purpose: </strong>In a Vietnamese teaching hospital, this study examined the prevalence and patterns of antimicrobial resistance (AMR) of common bacteria isolated from hospitalized patients with urinary tract infections (UTIs) between 2014 and 2021.</p><p><strong>Methods: </strong>From 4060 urine samples collected, common pathogens were isolated using quantitative culture on brilliance UTI Clarity agar and blood agar. Bacterial identification, antimicrobial susceptibility testing, and multidrug resistance (MDR) classification followed standardized techniques. Bacteria with a frequency of less than 2% were excluded. Statistical analysis was performed using R software, with the chi-square test applied and significance set at p < 0.05.</p><p><strong>Results: </strong>Of 4060 urine samples collected, 892 (22.0%) had positive results for common infections. Gram-negative bacteria predominated (591/892; 66.3%), with <i>Escherichia coli</i> being the most prevalent (336/892; 37.7%). <i>Enterococcus</i> spp. (152/892; 17.0%) was the leading Gram-positive pathogen. Some antibiotics had significant resistance rates, especially in Gram-negative bacteria, with ampicillin having the greatest resistance rate (92.8%). Carbapenems and nitrofurantoin remained generally effective. Among Gram-positive bacteria, high resistance was seen for macrolides ranging from 85.5% (azithromycin) to 89.8% (erythromycin), and for tetracyclines, ranging from 0% (teicoplanin) to 85.2% (tetracycline). There was no resistance to tigecycline and teicoplanin, indicating their potential efficacy against multidrug resistance (MDR) bacteria causing UTIs. MDR rates were higher in Gram-negative bacteria (64.8% versus 43.5%), with <i>Klebsiella pneumoniae</i> having the highest rate (78.7%).</p><p><strong>Conclusion: </strong>This study underscores the urgent need for ongoing surveillance of AMR patterns in Vietnam and emphasizes the significance of efficient infection prevention methods, prudent use of antibiotics, and targeted interventions to combat antimicrobial resistance.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"613-623"},"PeriodicalIF":2.9,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}